Patent details

EP2535354 Title: ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1

Basic Information

Publication number:
EP2535354
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP121700520
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
French Title of Invention:
Anticorps dirigés contre le récepteur humain de mort programmée PD-1
German Title of Invention:
Antikörper gegen den humanen programmed death Rezeptor PD-1
SPC Number:

Dates

Filing date:
13/06/2008
Grant date:
11/01/2017
EP Publication Date:
11/01/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/12/2012
EP B1 Publication Date:
11/01/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/06/2017
Expiration date:
13/06/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/06/2008
 
 

Name:
Merck Sharp & Dohme B.V.
Address:
Waarderweg 39, 2031 BN Haarlem, Netherlands (NL)

Inventor

1

Name:
Dulos Gradus Johannes
Address:
Netherlands (NL)

2

Name:
Van Eenennaam Hans
Address:
Netherlands (NL)

3

Name:
Carven Gregory John
Address:
United States (US)

Priority

Priority Number:
944583 P
Priority Date:
18/06/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages